Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANUSCO: Parenteral Nutrition in Pancreatic Cancer
NCT01362582Phase 3Terminated
- Sponsor
- National Center for Tumor Diseases
- Start
- Mar 2010
- Primary completion
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SmofKabiven Peripheral in pancreatic adenocarcinoma (PDAC), sponsored by National Center for Tumor Diseases. Started Mar 2010; status: terminated.
02
Drugs
SmofKabiven Peripheral
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01362582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01362582.